{"schema_version":"secwatch.filing_event.v1","accession":"0001179929-23-000021","form_type":"8-K","ticker":"MOH","cik":"0001179929","company_name":"MOLINA HEALTHCARE, INC.","filed_at":"2023-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.070882+00:00","generated_at":"2026-06-19T21:30:53.909880+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"Molina Healthcare Q4 2022 adj. EPS $4.10 vs $2.88 YoY; full-year adj. EPS $17.92 vs $13.54","bullets":["Q4 2022 premium revenue $7.9B, up 10.5% YoY; total revenue $8.2B.","Q4 GAAP diluted EPS $0.96, adjusted EPS $4.10; full-year GAAP EPS $13.55, adjusted $17.92.","Medical care ratio improved to 88.3% in Q4 from 88.8% a year ago; full-year MCR 88.0%.","After-tax margin expanded to 2.9% (adjusted) in Q4 from 2.3% in prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001179929-23-000021","json":"https://secwatch.observer/filing/0001179929-23-000021.json","markdown":"https://secwatch.observer/filing/0001179929-23-000021.md","text":"https://secwatch.observer/filing/0001179929-23-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1179929/000117992923000021/0001179929-23-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1179929/000117992923000021/moh-20230208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T21:30:53.909880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9937283487a63a339b317d7c4506ae47472dc4bc","claim":"MOLINA HEALTHCARE, INC. updated its the fourth quarter and year ended December 31, 2022 guidance (reaffirmed).","evidence_excerpt":"On February 8, 2023, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2022, and the Company’s full-year 2023 revenue and earnings guidance.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992923000021/0001179929-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and year ended December 31, 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}